Abiraterone Acetate
(UVIQSJCZCSLXRZ-UBUQANBQSA-N)
Structure
- SMILES
- CC(=O)O[C@H]1CC[C@]2(C(=CC[C@@H]3[C@@H]2CC[C@]2([C@H]3CC=C2c2cccnc2)C)C1)C
- Molecular Formula:
- C26H33NO2
- Molecular Weight:
- 391.546
- Log P:
- 5.9694
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 0
- TPSA:
- 39.19
- CAS Number(s):
- 154229-18-2
Synonym(s)
1.
Abiraterone Acetate
2.
17-(3-pyridyl)-5,16-androstadien-3beta-acetate
3.
CB 7630
4.
CB-7630
5.
CB7630
6.
Zytiga
External Link(s)
| MeSH | D000069501 |
| PubChem Compound | 9821849 |
| BindingDB | 50407398 |
| ChEBI | 68639 |
| CHEMBL | CHEMBL271227 |
| DrugCentral | 4176 |
| IUPHAR/BPS Guide to PHARMACOLOGY | 9288 |
| KEGG | dr:D09701 |
| Therapeutic Target Database | D06CNP |
| ZINC | 3809191 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 712 Canada Vigilance: 30 | Canada Vigilance US FAERS | |
| 2 | Therapy cessation | FAERS: 629 | US FAERS | |
| 3 | Drug dose omission | FAERS: 501 | US FAERS | |
| 4 | Fatigue | FAERS: 431 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 5 | Disease Progression | FAERS: 278 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 6 | Nausea | FAERS: 200 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 7 | Adverse event | FAERS: 195 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | Asthenia | FAERS: 186 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 9 | Malaise | FAERS: 155 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 10 | Dizziness | FAERS: 150 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 11 | Incorrect dose administered | FAERS: 135 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Pneumonia | FAERS: 133 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 13 | Weight decreased | FAERS: 118 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Vomiting | FAERS: 110 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 15 | Pain | FAERS: 104 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 16 | Urinary tract infection | FAERS: 103 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 17 | Constipation | FAERS: 98 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Product dose omission | FAERS: 93 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Arthralgia | FAERS: 86 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 20 | Peripheral swelling | FAERS: 86 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Headache | FAERS: 85 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 22 | Malignant neoplasm progression | FAERS: 77 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Myocardial Infarction | FAERS: 71 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 24 | Cerebrovascular accident | FAERS: 63 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 25 | Thrombocytopenia | FAERS: 63 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 26 | Wrong technique in product usage process | FAERS: 58 | US FAERS | |
| 27 | Myalgia | FAERS: 56 | US FAERS | |
| 28 | Product size issue | FAERS: 56 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 29 | Back Pain | FAERS: 54 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 30 | Inappropriate schedule of drug administration | FAERS: 53 | US FAERS | |
| 31 | Joint swelling | FAERS: 48 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 32 | Abdominal discomfort | FAERS: 46 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 33 | Dehydration | FAERS: 46 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 34 | Blood alkaline phosphatase increased | FAERS: 44 Canada Vigilance: 10 | Canada Vigilance US FAERS | |
| 35 | Sepsis | FAERS: 44 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 36 | Infection | FAERS: 43 | US FAERS | |
| 37 | Chest Pain | FAERS: 39 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 38 | Hospice Care | FAERS: 39 | US FAERS | |
| 39 | Atrial Fibrillation | FAERS: 38 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | Blood glucose increased | FAERS: 38 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 41 | Blood potassium decreased | FAERS: 36 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 42 | Feeling abnormal | FAERS: 36 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 43 | Influenza | FAERS: 36 | US FAERS | |
| 44 | Product difficult to swallow | FAERS: 35 | US FAERS | |
| 45 | Diabetes Mellitus | FAERS: 34 | US FAERS | |
| 46 | Nasopharyngitis | FAERS: 34 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 47 | treatment failure | FAERS: 34 | US FAERS | |
| 48 | Chemotherapy | FAERS: 33 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 49 | Bone pain | FAERS: 32 | US FAERS | |
| 50 | Pruritus | FAERS: 32 | US FAERS | |
| 51 | Memory impairment | FAERS: 31 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 52 | Product use complaint | FAERS: 30 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 53 | Somnolence | FAERS: 30 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 54 | Therapy change | FAERS: 29 | US FAERS | |
| 55 | Thrombosis | FAERS: 29 | US FAERS | |
| 56 | Blood urine present | FAERS: 27 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 57 | Hypotension | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 58 | Swelling | FAERS: 27 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 59 | General physical health deterioration | FAERS: 26 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 60 | Wrong technique in drug usage process | FAERS: 26 | US FAERS | |
| 61 | Abdominal Pain | FAERS: 25 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 62 | Amnesia | FAERS: 25 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 63 | Dementia | FAERS: 24 | US FAERS | |
| 64 | Dysuria | FAERS: 23 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 65 | Product use issue | FAERS: 23 | US FAERS | |
| 66 | Tremor | FAERS: 23 | US FAERS | |
| 67 | Alanine Aminotransferase Increased | FAERS: 22 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 68 | Aspartate Aminotransferase Increased | FAERS: 22 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 69 | Product use in unapproved indication | FAERS: 22 | US FAERS | |
| 70 | Unevaluable event | FAERS: 22 | US FAERS | |
| 71 | Product packaging quantity issue | FAERS: 20 | US FAERS | |
| 72 | Urinary Retention | FAERS: 20 | US FAERS | |
| 73 | Drug prescribing error | FAERS: 19 | US FAERS | |
| 74 | Dysgeusia | FAERS: 19 | US FAERS | |
| 75 | Cystitis | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 76 | Hepatotoxicity | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 77 | Palpitations | FAERS: 18 | US FAERS | |
| 78 | Cardiac Arrest | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 79 | Urticaria | FAERS: 17 | US FAERS | |
| 80 | Alopecia | FAERS: 16 | US FAERS | |
| 81 | Musculoskeletal Pain | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 82 | Pulmonary Embolism | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 83 | Visual Impairment | FAERS: 16 | US FAERS | |
| 84 | White blood cell count decreased | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 85 | Dyspepsia | FAERS: 15 | US FAERS | |
| 86 | Syncope | FAERS: 15 | US FAERS | |
| 87 | Vertigo | FAERS: 15 | US FAERS | |
| 88 | Abasia | FAERS: 14 | US FAERS | |
| 89 | Anxiety | FAERS: 14 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 90 | Ascites | FAERS: 14 | US FAERS | |
| 91 | Neutropenia | FAERS: 14 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 92 | Therapy non-responder | FAERS: 14 | US FAERS | |
| 93 | Ageusia | FAERS: 13 | US FAERS | |
| 94 | Bronchitis | FAERS: 13 | US FAERS | |
| 95 | Chromaturia | FAERS: 13 | US FAERS | |
| 96 | Erythema | FAERS: 13 | US FAERS | |
| 97 | Flatulence | FAERS: 13 | US FAERS | |
| 98 | Lethargy | FAERS: 13 | US FAERS | |
| 99 | Medication Error | FAERS: 13 | US FAERS | |
| 100 | Chills | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 101 | Metastasis | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 102 | Nephrolithiasis | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 103 | Oropharyngeal pain | FAERS: 12 | US FAERS | |
| 104 | Tachycardia | FAERS: 12 | US FAERS | |
| 105 | jaundice | FAERS: 12 | US FAERS | |
| 106 | Bedridden | FAERS: 11 | US FAERS | |
| 107 | Burning sensation | FAERS: 11 | US FAERS | |
| 108 | Diplopia | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 109 | Discomfort | FAERS: 11 | US FAERS | |
| 110 | Epistaxis | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 111 | Respiratory Failure | FAERS: 11 | US FAERS | |
| 112 | Toxicity to various agents | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 113 | Chest discomfort | FAERS: 10 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 114 | Dry skin | FAERS: 10 | US FAERS | |
| 115 | Fracture | FAERS: 10 | US FAERS | |
| 116 | Gamma-Glutamyltransferase Increased | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 117 | Hypersensitivity | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 118 | Hypersomnia | FAERS: 10 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 119 | Infarction | FAERS: 10 | US FAERS | |
| 120 | Night sweats | FAERS: 10 | US FAERS | |
| 121 | Product physical issue | FAERS: 10 | US FAERS | |
| 122 | Productive Cough | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 123 | Restless Legs Syndrome | FAERS: 10 | US FAERS | |
| 124 | Retching | FAERS: 10 | US FAERS | |
| 125 | Sinusitis | FAERS: 10 | US FAERS | |
| 126 | Blood creatinine increased | FAERS: 9 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 127 | Cardiotoxicity | FAERS: 9 | US FAERS | |
| 128 | Drug administration error | FAERS: 9 | US FAERS | |
| 129 | Drug resistance | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 130 | Gastrostomy | FAERS: 9 | US FAERS | |
| 131 | Leukopenia | FAERS: 9 | US FAERS | |
| 132 | Mood swings | FAERS: 9 | US FAERS | |
| 133 | Pancytopenia | FAERS: 9 | US FAERS | |
| 134 | Product quality issue | FAERS: 9 | US FAERS | |
| 135 | Prostatic specific antigen decreased | FAERS: 9 | US FAERS | |
| 136 | Transaminases increased | FAERS: 9 | US FAERS | |
| 137 | Urinary Incontinence | FAERS: 9 | US FAERS | |
| 138 | Acute Coronary Syndrome | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 139 | Blood testosterone increased | FAERS: 8 | US FAERS | |
| 140 | Extra dose administered | FAERS: 8 | US FAERS | |
| 141 | Intestinal Obstruction | FAERS: 8 | US FAERS | |
| 142 | Nocturia | FAERS: 8 | US FAERS | |
| 143 | Rhabdomyolysis | FAERS: 8 | US FAERS | |
| 144 | Sudden death | FAERS: 8 | US FAERS | |
| 145 | Abscess | FAERS: 7 | US FAERS | |
| 146 | Accidental overdose | FAERS: 7 | US FAERS | |
| 147 | Acute kidney injury | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 148 | Blood glucose decreased | FAERS: 7 | US FAERS | |
| 149 | Blood sodium decreased | FAERS: 7 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 150 | Cellulitis | FAERS: 7 | US FAERS | |
| 151 | Cholelithiasis | FAERS: 7 | US FAERS | |
| 152 | Deafness | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 153 | Disease complication | FAERS: 7 | US FAERS | |
| 154 | Disorientation | FAERS: 7 | US FAERS | |
| 155 | Economic problem | FAERS: 7 | US FAERS | |
| 156 | Flushing | FAERS: 7 | US FAERS | |
| 157 | Full blood count decreased | FAERS: 7 | US FAERS | |
| 158 | Gait inability | FAERS: 7 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 159 | Hypertensive crisis | FAERS: 7 | US FAERS | |
| 160 | Hypophagia | FAERS: 7 | US FAERS | |
| 161 | Incorrect product storage | FAERS: 7 | US FAERS | |
| 162 | Increased tendency to bruise | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 163 | Limb injury | FAERS: 7 | US FAERS | |
| 164 | Musculoskeletal discomfort | FAERS: 7 | US FAERS | |
| 165 | Musculoskeletal stiffness | FAERS: 7 | US FAERS | |
| 166 | Neck Pain | FAERS: 7 | US FAERS | |
| 167 | Neuralgia | FAERS: 7 | US FAERS | |
| 168 | Pancreatitis | FAERS: 7 | US FAERS | |
| 169 | Prescribed underdose | FAERS: 7 | US FAERS | |
| 170 | Product counterfeit | FAERS: 7 | US FAERS | |
| 171 | Renal pain | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 172 | Septic Shock | FAERS: 7 | US FAERS | |
| 173 | Blood albumin increased | FAERS: 6 | US FAERS | |
| 174 | Blood cholesterol increased | FAERS: 6 | US FAERS | |
| 175 | Cataract | FAERS: 6 | US FAERS | |
| 176 | Drug effect incomplete | FAERS: 6 | US FAERS | |
| 177 | Electrolyte imbalance | FAERS: 6 | US FAERS | |
| 178 | Emotional disorder | FAERS: 6 | US FAERS | |
| 179 | Hernia | FAERS: 6 | US FAERS | |
| 180 | Pneumonitis | FAERS: 6 | US FAERS | |
| 181 | Pulmonary thrombosis | FAERS: 6 | US FAERS | |
| 182 | Quality of life decreased | FAERS: 6 | US FAERS | |
| 183 | Stomatitis | FAERS: 6 | US FAERS | |
| 184 | Terminal state | FAERS: 6 | US FAERS | |
| 185 | Urinary tract obstruction | FAERS: 6 | US FAERS | |
| 186 | Blood triglycerides increased | FAERS: 5 | US FAERS | |
| 187 | Choking | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 188 | Clostridium difficile infection | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 189 | Crying | FAERS: 5 | US FAERS | |
| 190 | Diabetes mellitus inadequate control | FAERS: 5 | US FAERS | |
| 191 | Ileus | FAERS: 5 | US FAERS | |
| 192 | Incontinence | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 193 | Initial insomnia | FAERS: 5 | US FAERS | |
| 194 | Lower respiratory tract infection | FAERS: 5 | US FAERS | |
| 195 | Lymphoma | FAERS: 5 | US FAERS | |
| 196 | Mental impairment | FAERS: 5 | US FAERS | |
| 197 | Middle insomnia | FAERS: 5 | US FAERS | |
| 198 | Muscle tightness | FAERS: 5 | US FAERS | |
| 199 | Musculoskeletal chest pain | FAERS: 5 | US FAERS | |
| 200 | Nonspecific reaction | FAERS: 5 | US FAERS | |
| 201 | Oral infection | FAERS: 5 | US FAERS | |
| 202 | Photophobia | FAERS: 5 | US FAERS | |
| 203 | Poor quality drug administered | FAERS: 5 | US FAERS | |
| 204 | Product prescribing error | FAERS: 5 | US FAERS | |
| 205 | Skin lesion | FAERS: 5 | US FAERS | |
| 206 | Therapeutic response unexpected | FAERS: 5 | US FAERS | |
| 207 | Tinnitus | FAERS: 5 | US FAERS | |
| 208 | Ulcer | FAERS: 5 | US FAERS | |
| 209 | Angina Pectoris | FAERS: 4 | US FAERS | |
| 210 | Angioedema | FAERS: 4 | US FAERS | |
| 211 | Arthritis | FAERS: 4 | US FAERS | |
| 212 | Asthma | FAERS: 4 | US FAERS | |
| 213 | Back disorder | FAERS: 4 | US FAERS | |
| 214 | Blood magnesium decreased | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 215 | Bone lesion | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 216 | Cerebral Infarction | FAERS: 4 | US FAERS | |
| 217 | Colitis | FAERS: 4 | US FAERS | |
| 218 | Deep Vein Thrombosis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 219 | Depressed Level of Consciousness | FAERS: 4 | US FAERS | |
| 220 | Depressed mood | FAERS: 4 | US FAERS | |
| 221 | Device occlusion | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 222 | Drug dispensing error | FAERS: 4 | US FAERS | |
| 223 | Dysphonia | FAERS: 4 | US FAERS | |
| 224 | Ejection Fraction Decreased | FAERS: 4 | US FAERS | |
| 225 | Embolism | FAERS: 4 | US FAERS | |
| 226 | Gastritis | FAERS: 4 | US FAERS | |
| 227 | Gout | FAERS: 4 | US FAERS | |
| 228 | Hepatitis B | FAERS: 4 | US FAERS | |
| 229 | Hepatitis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 230 | Hepatomegaly | FAERS: 4 | US FAERS | |
| 231 | Hunger | FAERS: 4 | US FAERS | |
| 232 | Hypothyroidism | FAERS: 4 | US FAERS | |
| 233 | Inappropriate schedule of product administration | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 234 | Living in residential institution | FAERS: 4 | US FAERS | |
| 235 | Loss of personal independence in daily activities | FAERS: 4 | US FAERS | |
| 236 | Monoplegia | FAERS: 4 | US FAERS | |
| 237 | Overdose | FAERS: 4 | US FAERS | |
| 238 | Performance status decreased | FAERS: 4 | US FAERS | |
| 239 | Product packaging issue | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 240 | Product storage error | FAERS: 4 | US FAERS | |
| 241 | Skin Ulcer | FAERS: 4 | US FAERS | |
| 242 | Suspected counterfeit product | FAERS: 4 | US FAERS | |
| 243 | Tooth Extraction | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 244 | Troponin increased | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 245 | Wheelchair user | FAERS: 4 | US FAERS | |
| 246 | Accidental exposure to product | FAERS: 3 | US FAERS | |
| 247 | Acute myocardial infarction | FAERS: 3 | US FAERS | |
| 248 | Acute respiratory failure | FAERS: 3 | US FAERS | |
| 249 | Agitation | FAERS: 3 | US FAERS | |
| 250 | Altered state of consciousness | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 251 | Amylase increased | FAERS: 3 | US FAERS | |
| 252 | Aphasia | FAERS: 3 | US FAERS | |
| 253 | Asphyxia | FAERS: 3 | US FAERS | |
| 254 | Bladder neoplasm surgery | FAERS: 3 | US FAERS | |
| 255 | Blood count abnormal | FAERS: 3 | US FAERS | |
| 256 | Blood creatine phosphokinase MB increased | FAERS: 3 | US FAERS | |
| 257 | Blood creatine phosphokinase increased | FAERS: 3 | US FAERS | |
| 258 | Blood glucose fluctuation | FAERS: 3 | US FAERS | |
| 259 | Blood phosphorus decreased | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 260 | Bradycardia | FAERS: 3 | US FAERS | |
| 261 | Cancer Pain | FAERS: 3 | US FAERS | |
| 262 | Cauda Equina Syndrome | FAERS: 3 | US FAERS | |
| 263 | Cholestasis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 264 | Complication associated with device | FAERS: 3 | US FAERS | |
| 265 | Decreased immune responsiveness | FAERS: 3 | US FAERS | |
| 266 | Dermatitis | FAERS: 3 | US FAERS | |
| 267 | Device related infection | FAERS: 3 | US FAERS | |
| 268 | Duodenal Ulcer | FAERS: 3 | US FAERS | |
| 269 | Dysarthria | FAERS: 3 | US FAERS | |
| 270 | Erythema Multiforme | FAERS: 3 | US FAERS | |
| 271 | Exposure via body fluid | FAERS: 3 | US FAERS | |
| 272 | Gastric ulcer | FAERS: 3 | US FAERS | |
| 273 | Gastrointestinal Pain | FAERS: 3 | US FAERS | |
| 274 | General physical condition abnormal | FAERS: 3 | US FAERS | |
| 275 | Glaucoma | FAERS: 3 | US FAERS | |
| 276 | Incorrect storage of drug | FAERS: 3 | US FAERS | |
| 277 | Intentional product use issue | FAERS: 3 | US FAERS | |
| 278 | Intestinal Perforation | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 279 | Joint stiffness | FAERS: 3 | US FAERS | |
| 280 | Laceration | FAERS: 3 | US FAERS | |
| 281 | Lipase increased | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 282 | Lymphadenopathy | FAERS: 3 | US FAERS | |
| 283 | Lymphangiosis carcinomatosa | FAERS: 3 | US FAERS | |
| 284 | Metastatic Neoplasm | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 285 | Mouth swelling | FAERS: 3 | US FAERS | |
| 286 | Muscle strain | FAERS: 3 | US FAERS | |
| 287 | Myopathy | FAERS: 3 | US FAERS | |
| 288 | Necrosis | FAERS: 3 | US FAERS | |
| 289 | Nervousness | FAERS: 3 | US FAERS | |
| 290 | Neutrophil count decreased | FAERS: 3 | US FAERS | |
| 291 | No adverse event | FAERS: 3 | US FAERS | |
| 292 | Oliguria | FAERS: 3 | US FAERS | |
| 293 | Oncologic complication | FAERS: 3 | US FAERS | |
| 294 | Osteonecrosis of Jaw | FAERS: 3 | US FAERS | |
| 295 | Osteoporosis | FAERS: 3 | US FAERS | |
| 296 | Pelvic Pain | FAERS: 3 | US FAERS | |
| 297 | Penile size reduced | FAERS: 3 | US FAERS | |
| 298 | Pericardial effusion | FAERS: 3 | US FAERS | |
| 299 | Petechiae | FAERS: 3 | US FAERS | |
| 300 | Pneumothorax | FAERS: 3 | US FAERS | |
| 301 | Poor quality sleep | FAERS: 3 | US FAERS | |
| 302 | Presyncope | FAERS: 3 | US FAERS | |
| 303 | Prostate cancer recurrent | FAERS: 3 | US FAERS | |
| 304 | Prostatectomy | FAERS: 3 | US FAERS | |
| 305 | Pulmonary Hypertension | FAERS: 3 | US FAERS | |
| 306 | Purpura | FAERS: 3 | US FAERS | |
| 307 | Radiation injury | FAERS: 3 | US FAERS | |
| 308 | Respiratory arrest | FAERS: 3 | US FAERS | |
| 309 | Restlessness | FAERS: 3 | US FAERS | |
| 310 | Retinal Detachment | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 311 | Skin reaction | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 312 | Stevens-Johnson Syndrome | FAERS: 3 | US FAERS | |
| 313 | Systolic hypertension | FAERS: 3 | US FAERS | |
| 314 | Therapeutic procedure | FAERS: 3 | US FAERS | |
| 315 | Therapeutic product ineffective | FAERS: 3 | US FAERS | |
| 316 | Thirst | FAERS: 3 | US FAERS | |
| 317 | Throat irritation | FAERS: 3 | US FAERS | |
| 318 | Tooth Loss | FAERS: 3 | US FAERS | |
| 319 | Toothache | FAERS: 3 | US FAERS | |
| 320 | Urine output increased | FAERS: 3 | US FAERS | |
| 321 | Uveitis | FAERS: 3 | US FAERS | |
| 322 | intensive care | FAERS: 3 | US FAERS | |
| 323 | nervous system disorder | FAERS: 3 | US FAERS | |
| 324 | Acne | FAERS: 2 | US FAERS | |
| 325 | Activities of daily living impaired | FAERS: 2 | US FAERS | |
| 326 | Amaurosis Fugax | FAERS: 2 | US FAERS | |
| 327 | Anger | FAERS: 2 | US FAERS | |
| 328 | Anticoagulation drug level above therapeutic | FAERS: 2 | US FAERS | |
| 329 | Aphagia | FAERS: 2 | US FAERS | |
| 330 | Appendicitis | FAERS: 2 | US FAERS | |
| 331 | Arthropod bite | FAERS: 2 | US FAERS | |
| 332 | Atrial Flutter | FAERS: 2 | US FAERS | |
| 333 | Basal cell carcinoma | FAERS: 2 | US FAERS | |
| 334 | Biopsy | FAERS: 2 | US FAERS | |
| 335 | Bladder Neoplasm | FAERS: 2 | US FAERS | |
| 336 | Blindness | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 337 | Blood aldosterone increased | FAERS: 2 | US FAERS | |
| 338 | Blood bilirubin abnormal | FAERS: 2 | US FAERS | |
| 339 | Blood blister | FAERS: 2 | US FAERS | |
| 340 | Blood electrolytes abnormal | FAERS: 2 | US FAERS | |
| 341 | Blood glucose abnormal | FAERS: 2 | US FAERS | |
| 342 | Blood potassium abnormal | FAERS: 2 | US FAERS | |
| 343 | Blood potassium increased | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 344 | Blood thyroid stimulating hormone increased | FAERS: 2 | US FAERS | |
| 345 | Blood urea increased | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 346 | Breast tenderness | FAERS: 2 | US FAERS | |
| 347 | Bronchospasm | FAERS: 2 | US FAERS | |
| 348 | Catheter placement | FAERS: 2 | US FAERS | |
| 349 | Cerebral Thrombosis | FAERS: 2 | US FAERS | |
| 350 | Cholangitis | FAERS: 2 | US FAERS | |
| 351 | Cholecystitis | FAERS: 2 | US FAERS | |
| 352 | Completed Suicide | FAERS: 2 | US FAERS | |
| 353 | Critical Illness | FAERS: 2 | US FAERS | |
| 354 | Delirium | FAERS: 2 | US FAERS | |
| 355 | Dental Restoration Failure | FAERS: 2 | US FAERS | |
| 356 | Disease recurrence | FAERS: 2 | US FAERS | |
| 357 | Electrocardiogram repolarisation abnormality | FAERS: 2 | US FAERS | |
| 358 | Electrolyte depletion | FAERS: 2 | US FAERS | |
| 359 | Encephalitis | FAERS: 2 | US FAERS | |
| 360 | Endocarditis | FAERS: 2 | US FAERS | |
| 361 | Erectile dysfunction | FAERS: 2 | US FAERS | |
| 362 | Eructation | FAERS: 2 | US FAERS | |
| 363 | Escherichia urinary tract infection | FAERS: 2 | US FAERS | |
| 364 | Expired product administered | FAERS: 2 | US FAERS | |
| 365 | Eye inflammation | FAERS: 2 | US FAERS | |
| 366 | Eye pain | FAERS: 2 | US FAERS | |
| 367 | Failure to Thrive | FAERS: 2 | US FAERS | |
| 368 | Fanconi Syndrome | FAERS: 2 | US FAERS | |
| 369 | Fluid overload | FAERS: 2 | US FAERS | |
| 370 | Gastroenteritis | FAERS: 2 | US FAERS | |
| 371 | Gastrointestinal carcinoma | FAERS: 2 | US FAERS | |
| 372 | Gastrointestinal infection | FAERS: 2 | US FAERS | |
| 373 | Gastrointestinal inflammation | FAERS: 2 | US FAERS | |
| 374 | Gastrointestinal obstruction | FAERS: 2 | US FAERS | |
| 375 | Hemiplegia | FAERS: 2 | US FAERS | |
| 376 | Hip surgery | FAERS: 2 | US FAERS | |
| 377 | Hydronephrosis | FAERS: 2 | US FAERS | |
| 378 | Hyperacusis | FAERS: 2 | US FAERS | |
| 379 | Hyperchlorhydria | FAERS: 2 | US FAERS | |
| 380 | Hypokinesia | FAERS: 2 | US FAERS | |
| 381 | Incoherent | FAERS: 2 | US FAERS | |
| 382 | Joint injury | FAERS: 2 | US FAERS | |
| 383 | Leukocytosis | FAERS: 2 | US FAERS | |
| 384 | Limb discomfort | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 385 | Limb operation | FAERS: 2 | US FAERS | |
| 386 | Lip swelling | FAERS: 2 | US FAERS | |
| 387 | Liver function test decreased | FAERS: 2 | US FAERS | |
| 388 | Lower respiratory tract inflammation | FAERS: 2 | US FAERS | |
| 389 | Lymphopenia | FAERS: 2 | US FAERS | |
| 390 | Macular degeneration | FAERS: 2 | US FAERS | |
| 391 | Malnutrition | FAERS: 2 | US FAERS | |
| 392 | Mental status changes | FAERS: 2 | US FAERS | |
| 393 | Nephrotic Syndrome | FAERS: 2 | US FAERS | |
| 394 | Oral pain | FAERS: 2 | US FAERS | |
| 395 | Pain of skin | FAERS: 2 | US FAERS | |
| 396 | Paraplegia | FAERS: 2 | US FAERS | |
| 397 | Pathological fracture | FAERS: 2 | US FAERS | |
| 398 | Pericarditis | FAERS: 2 | US FAERS | |
| 399 | Perineal pain | FAERS: 2 | US FAERS | |
| 400 | Procedural complication | FAERS: 2 | US FAERS | |
| 401 | Product coating issue | FAERS: 2 | US FAERS | |
| 402 | Product dispensing error | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 403 | Product label confusion | FAERS: 2 | US FAERS | |
| 404 | Pulmonary congestion | FAERS: 2 | US FAERS | |
| 405 | Pulmonary sepsis | FAERS: 2 | US FAERS | |
| 406 | Rash erythematous | FAERS: 2 | US FAERS | |
| 407 | Rectal discharge | FAERS: 2 | US FAERS | |
| 408 | Respiratory distress | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 409 | Sarcopenia | FAERS: 2 | US FAERS | |
| 410 | Screaming | FAERS: 2 | US FAERS | |
| 411 | Spinal column stenosis | FAERS: 2 | US FAERS | |
| 412 | Subcutaneous Abscess | FAERS: 2 | US FAERS | |
| 413 | Temperature intolerance | FAERS: 2 | US FAERS | |
| 414 | Tooth Infection | FAERS: 2 | US FAERS | |
| 415 | Transaminases abnormal | FAERS: 2 | US FAERS | |
| 416 | Trigeminal Neuralgia | FAERS: 2 | US FAERS | |
| 417 | Tuberculosis | FAERS: 2 | US FAERS | |
| 418 | Tumour haemorrhage | FAERS: 2 | US FAERS | |
| 419 | Ureteral stent insertion | FAERS: 2 | US FAERS | |
| 420 | Urethral Stenosis | FAERS: 2 | US FAERS | |
| 421 | Vasculitis | FAERS: 2 | US FAERS | |
| 422 | Vertebroplasty | FAERS: 2 | US FAERS | |
| 423 | Wound Infection | FAERS: 2 | US FAERS | |
| 424 | Wrong dose | FAERS: 2 | US FAERS | |
| 425 | Abdominal sepsis | FAERS: 1 | US FAERS | |
| 426 | Abdominal symptom | FAERS: 1 | US FAERS | |
| 427 | Accidental underdose | FAERS: 1 | US FAERS | |
| 428 | Adulterated product | FAERS: 1 | US FAERS | |
| 429 | Agranulocytosis | FAERS: 1 | US FAERS | |
| 430 | Altered visual depth perception | FAERS: 1 | US FAERS | |
| 431 | Alveolitis | FAERS: 1 | US FAERS | |
| 432 | Amputation | FAERS: 1 | US FAERS | |
| 433 | Anal abscess | FAERS: 1 | US FAERS | |
| 434 | Aneurysm | FAERS: 1 | US FAERS | |
| 435 | Angle Closure Glaucoma | FAERS: 1 | US FAERS | |
| 436 | Arterial thrombosis | FAERS: 1 | US FAERS | |
| 437 | Arteritis | FAERS: 1 | US FAERS | |
| 438 | Arthropathy | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 439 | Atelectasis | FAERS: 1 | US FAERS | |
| 440 | Atrioventricular Septal Defect | FAERS: 1 | US FAERS | |
| 441 | Autonomic nervous system imbalance | FAERS: 1 | US FAERS | |
| 442 | Bilirubin conjugated increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 443 | Bladder pain | FAERS: 1 | US FAERS | |
| 444 | Bladder tamponade | FAERS: 1 | US FAERS | |
| 445 | Blood albumin abnormal | FAERS: 1 | US FAERS | |
| 446 | Blood albumin decreased | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 447 | Blood alkaline phosphatase abnormal | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 448 | Blood cortisol decreased | FAERS: 1 | US FAERS | |
| 449 | Blood creatine increased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 450 | Blood creatinine abnormal | FAERS: 1 | US FAERS | |
| 451 | Blood insulin abnormal | FAERS: 1 | US FAERS | |
| 452 | Blood parathyroid hormone increased | FAERS: 1 | US FAERS | |
| 453 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 454 | Blood testosterone decreased | FAERS: 1 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 455 | Bone density decreased | FAERS: 1 | US FAERS | |
| 456 | Bronchiolitis | FAERS: 1 | US FAERS | |
| 457 | Bursitis | FAERS: 1 | US FAERS | |
| 458 | Cachexia | FAERS: 1 | US FAERS | |
| 459 | Cardiac Death | FAERS: 1 | US FAERS | |
| 460 | Cardiac Flutter | FAERS: 1 | US FAERS | |
| 461 | Cardiac assistance device user | FAERS: 1 | US FAERS | |
| 462 | Cardiac dysfunction | FAERS: 1 | US FAERS | |
| 463 | Cardiac infection | FAERS: 1 | US FAERS | |
| 464 | Cardiomegaly | FAERS: 1 | US FAERS | |
| 465 | Cardiovascular insufficiency | FAERS: 1 | US FAERS | |
| 466 | Carotid Artery Thrombosis | FAERS: 1 | US FAERS | |
| 467 | Carotid artery occlusion | FAERS: 1 | US FAERS | |
| 468 | Cataract operation | FAERS: 1 | US FAERS | |
| 469 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 470 | Cheilitis | FAERS: 1 | US FAERS | |
| 471 | Clostridium difficile colitis | FAERS: 1 | US FAERS | |
| 472 | Cluster Headache | FAERS: 1 | US FAERS | |
| 473 | Cold sweat | FAERS: 1 | US FAERS | |
| 474 | Compression fracture | FAERS: 1 | US FAERS | |
| 475 | Consciousness fluctuating | FAERS: 1 | US FAERS | |
| 476 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 477 | Crystal urine present | FAERS: 1 | US FAERS | |
| 478 | Death of relative | FAERS: 1 | US FAERS | |
| 479 | Demyelination | FAERS: 1 | US FAERS | |
| 480 | Dengue Fever | FAERS: 1 | US FAERS | |
| 481 | Dental caries | FAERS: 1 | US FAERS | |
| 482 | Diet refusal | FAERS: 1 | US FAERS | |
| 483 | Disability | FAERS: 1 | US FAERS | |
| 484 | Disseminated Intravascular Coagulation | FAERS: 1 | US FAERS | |
| 485 | Disuse syndrome | FAERS: 1 | US FAERS | |
| 486 | Diverticulitis | FAERS: 1 | US FAERS | |
| 487 | Diverticulum | FAERS: 1 | US FAERS | |
| 488 | Drug Tolerance | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 489 | Drug abuse | FAERS: 1 | US FAERS | |
| 490 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 491 | Drug level below therapeutic | FAERS: 1 | US FAERS | |
| 492 | Drug level increased | FAERS: 1 | US FAERS | |
| 493 | Dysacusis | FAERS: 1 | US FAERS | |
| 494 | Dysphemia | FAERS: 1 | US FAERS | |
| 495 | Eczema | FAERS: 1 | US FAERS | |
| 496 | Emergency Care | FAERS: 1 | US FAERS | |
| 497 | Emotional distress | FAERS: 1 | US FAERS | |
| 498 | Enteritis | FAERS: 1 | US FAERS | |
| 499 | Enterococcal infection | FAERS: 1 | US FAERS | |
| 500 | Enzyme abnormality | FAERS: 1 | US FAERS | |
| 501 | Enzyme level increased | FAERS: 1 | US FAERS | |
| 502 | Epidermal growth factor receptor decreased | FAERS: 1 | US FAERS | |
| 503 | Epilepsy | FAERS: 1 | US FAERS | |
| 504 | Erysipelas | FAERS: 1 | US FAERS | |
| 505 | Escherichia infection | FAERS: 1 | US FAERS | |
| 506 | Excoriation | FAERS: 1 | US FAERS | |
| 507 | Expired drug administered | FAERS: 1 | US FAERS | |
| 508 | Exposed bone in jaw | FAERS: 1 | US FAERS | |
| 509 | Exposure via partner | FAERS: 1 | US FAERS | |
| 510 | Extraocular Muscle Paresis | FAERS: 1 | US FAERS | |
| 511 | Extremity necrosis | FAERS: 1 | US FAERS | |
| 512 | Eye irritation | FAERS: 1 | US FAERS | |
| 513 | Facial paralysis | FAERS: 1 | US FAERS | |
| 514 | Febrile Neutropenia | FAERS: 1 | US FAERS | |
| 515 | Feeling Cold | FAERS: 1 | US FAERS | |
| 516 | Feeling jittery | FAERS: 1 | US FAERS | |
| 517 | Fibrin D dimer increased | FAERS: 1 | US FAERS | |
| 518 | Flank Pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 519 | Folliculitis | FAERS: 1 | US FAERS | |
| 520 | Food Poisoning | FAERS: 1 | US FAERS | |
| 521 | Food craving | FAERS: 1 | US FAERS | |
| 522 | Foreign body in respiratory tract | FAERS: 1 | US FAERS | |
| 523 | Formication | FAERS: 1 | US FAERS | |
| 524 | Gastrectomy | FAERS: 1 | US FAERS | |
| 525 | Gastric pH decreased | FAERS: 1 | US FAERS | |
| 526 | Gastroenteritis norovirus | FAERS: 1 | US FAERS | |
| 527 | Gastrointestinal angiodysplasia | FAERS: 1 | US FAERS | |
| 528 | Gastrointestinal motility disorder | FAERS: 1 | US FAERS | |
| 529 | Gastrointestinal ulcer | FAERS: 1 | US FAERS | |
| 530 | Gingivitis | FAERS: 1 | US FAERS | |
| 531 | Guillain-Barre Syndrome | FAERS: 1 | US FAERS | |
| 532 | Head discomfort | FAERS: 1 | US FAERS | |
| 533 | Heat Exhaustion | FAERS: 1 | US FAERS | |
| 534 | Hemiparesis | FAERS: 1 | US FAERS | |
| 535 | Hepatic cancer metastatic | FAERS: 1 | US FAERS | |
| 536 | Hepatitis C | FAERS: 1 | US FAERS | |
| 537 | Hormone Therapy | FAERS: 1 | US FAERS | |
| 538 | Hydrocephalus | FAERS: 1 | US FAERS | |
| 539 | Hypercapnia | FAERS: 1 | US FAERS | |
| 540 | Hyperexplexia | FAERS: 1 | US FAERS | |
| 541 | Hyperkeratosis | FAERS: 1 | US FAERS | |
| 542 | Hypertensive heart disease | FAERS: 1 | US FAERS | |
| 543 | Hypertransaminasaemia | FAERS: 1 | US FAERS | |
| 544 | Hypogonadism | FAERS: 1 | US FAERS | |
| 545 | Immobile | FAERS: 1 | US FAERS | |
| 546 | Impaired driving ability | FAERS: 1 | US FAERS | |
| 547 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 548 | Impaired self-care | FAERS: 1 | US FAERS | |
| 549 | Incorrect route of product administration | FAERS: 1 | US FAERS | |
| 550 | Increased upper airway secretion | FAERS: 1 | US FAERS | |
| 551 | Increased viscosity of upper respiratory secretion | FAERS: 1 | US FAERS | |
| 552 | Infectious pleural effusion | FAERS: 1 | US FAERS | |
| 553 | Inflammation | FAERS: 1 | US FAERS | |
| 554 | Infrequent bowel movements | FAERS: 1 | US FAERS | |
| 555 | Injection site infection | FAERS: 1 | US FAERS | |
| 556 | Insurance issue | FAERS: 1 | US FAERS | |
| 557 | Intentional drug misuse | FAERS: 1 | US FAERS | |
| 558 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 559 | Intentional self-injury | FAERS: 1 | US FAERS | |
| 560 | Intervertebral disc disorder | FAERS: 1 | US FAERS | |
| 561 | Intra-abdominal fluid collection | FAERS: 1 | US FAERS | |
| 562 | Irritable Bowel Syndrome | FAERS: 1 | US FAERS | |
| 563 | Large intestine perforation | FAERS: 1 | US FAERS | |
| 564 | Laryngitis | FAERS: 1 | US FAERS | |
| 565 | Limb mass | FAERS: 1 | US FAERS | |
| 566 | Lipoatrophy | FAERS: 1 | US FAERS | |
| 567 | Lung perforation | FAERS: 1 | US FAERS | |
| 568 | Lymphangitis | FAERS: 1 | US FAERS | |
| 569 | Lymphocyte count decreased | FAERS: 1 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 570 | Mantle cell lymphoma recurrent | FAERS: 1 | US FAERS | |
| 571 | Mechanical ventilation | FAERS: 1 | US FAERS | |
| 572 | Medical device site pain | FAERS: 1 | US FAERS | |
| 573 | Medical diet | FAERS: 1 | US FAERS | |
| 574 | Medical procedure | FAERS: 1 | US FAERS | |
| 575 | Medication residue present | FAERS: 1 | US FAERS | |
| 576 | Meningioma | FAERS: 1 | US FAERS | |
| 577 | Meniscus injury | FAERS: 1 | US FAERS | |
| 578 | Mental disorder due to a general medical condition | FAERS: 1 | US FAERS | |
| 579 | Metastases to adrenals | FAERS: 1 | US FAERS | |
| 580 | Metastatic pain | FAERS: 1 | US FAERS | |
| 581 | Micturition frequency decreased | FAERS: 1 | US FAERS | |
| 582 | Mineral supplementation | FAERS: 1 | US FAERS | |
| 583 | Muscle Fatigue | FAERS: 1 | US FAERS | |
| 584 | Myasthenia Gravis | FAERS: 1 | US FAERS | |
| 585 | Myocarditis | FAERS: 1 | US FAERS | |
| 586 | Nail Infection | FAERS: 1 | US FAERS | |
| 587 | Nasal pruritus | FAERS: 1 | US FAERS | |
| 588 | Nerve injury | FAERS: 1 | US FAERS | |
| 589 | Neurological eyelid disorder | FAERS: 1 | US FAERS | |
| 590 | Nipple pain | FAERS: 1 | US FAERS | |
| 591 | Obesity | FAERS: 1 | US FAERS | |
| 592 | Obstruction | FAERS: 1 | US FAERS | |
| 593 | Oculomucocutaneous syndrome | FAERS: 1 | US FAERS | |
| 594 | Onychoclasis | FAERS: 1 | US FAERS | |
| 595 | Opiates positive | FAERS: 1 | US FAERS | |
| 596 | Optic Atrophy | FAERS: 1 | US FAERS | |
| 597 | Optic Neuropathy | FAERS: 1 | US FAERS | |
| 598 | Osteomyelitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 599 | Palliative Care | FAERS: 1 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 600 | Palmar erythema | FAERS: 1 | US FAERS | |
| 601 | Pancreatic carcinoma | FAERS: 1 | US FAERS | |
| 602 | Paranasal sinus discomfort | FAERS: 1 | US FAERS | |
| 603 | Paranasal sinus hypersecretion | FAERS: 1 | US FAERS | |
| 604 | Paranoia | FAERS: 1 | US FAERS | |
| 605 | Paraparesis | FAERS: 1 | US FAERS | |
| 606 | Pelvic discomfort | FAERS: 1 | US FAERS | |
| 607 | Peripheral arterial occlusive disease | FAERS: 1 | US FAERS | |
| 608 | Peripheral embolism | FAERS: 1 | US FAERS | |
| 609 | Peripheral motor neuropathy | FAERS: 1 | US FAERS | |
| 610 | Peripheral nerve lesion | FAERS: 1 | US FAERS | |
| 611 | Pharyngitis | FAERS: 1 | US FAERS | |
| 612 | Physical product label issue | FAERS: 1 | US FAERS | |
| 613 | Platelet count abnormal | FAERS: 1 | US FAERS | |
| 614 | Poisoning | FAERS: 1 | US FAERS | |
| 615 | Poor quality product administered | FAERS: 1 | US FAERS | |
| 616 | Portal Hypertension | FAERS: 1 | US FAERS | |
| 617 | Post procedural complication | FAERS: 1 | US FAERS | |
| 618 | Post procedural infection | FAERS: 1 | US FAERS | |
| 619 | Product administration error | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 620 | Product complaint | FAERS: 1 | US FAERS | |
| 621 | Product container seal issue | FAERS: 1 | US FAERS | |
| 622 | Product distribution issue | FAERS: 1 | US FAERS | |
| 623 | Product lot number issue | FAERS: 1 | US FAERS | |
| 624 | Product shape issue | FAERS: 1 | US FAERS | |
| 625 | Product solubility abnormal | FAERS: 1 | US FAERS | |
| 626 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 627 | Prostate ablation | FAERS: 1 | US FAERS | |
| 628 | Psoriasis | FAERS: 1 | US FAERS | |
| 629 | Psychiatric symptom | FAERS: 1 | US FAERS | |
| 630 | Pulmonary Fibrosis | FAERS: 1 | US FAERS | |
| 631 | Pulmonary pain | FAERS: 1 | US FAERS | |
| 632 | Pyelonephritis | FAERS: 1 | US FAERS | |
| 633 | Radiation associated pain | FAERS: 1 | US FAERS | |
| 634 | Rales | FAERS: 1 | US FAERS | |
| 635 | Reactive gastropathy | FAERS: 1 | US FAERS | |
| 636 | Rectal Stenosis | FAERS: 1 | US FAERS | |
| 637 | Rectal injury | FAERS: 1 | US FAERS | |
| 638 | Refractory cancer | FAERS: 1 | US FAERS | |
| 639 | Rehabilitation therapy | FAERS: 1 | US FAERS | |
| 640 | Relapsing Fever | FAERS: 1 | US FAERS | |
| 641 | Renal Colic | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 642 | Renal artery stent placement | FAERS: 1 | US FAERS | |
| 643 | Renal cancer metastatic | FAERS: 1 | US FAERS | |
| 644 | Renal tubular necrosis | FAERS: 1 | US FAERS | |
| 645 | Retroperitoneal fibrosis | FAERS: 1 | US FAERS | |
| 646 | Rhinovirus infection | FAERS: 1 | US FAERS | |
| 647 | Saliva altered | FAERS: 1 | US FAERS | |
| 648 | Salivary Duct Inflammation | FAERS: 1 | US FAERS | |
| 649 | Secretion discharge | FAERS: 1 | US FAERS | |
| 650 | Seizure like phenomena | FAERS: 1 | US FAERS | |
| 651 | Severe Acute Respiratory Syndrome | FAERS: 1 | US FAERS | |
| 652 | Sexual Dysfunction | FAERS: 1 | US FAERS | |
| 653 | Sigmoiditis | FAERS: 1 | US FAERS | |
| 654 | Silent myocardial infarction | FAERS: 1 | US FAERS | |
| 655 | Skin discomfort | FAERS: 1 | US FAERS | |
| 656 | Skin irritation | FAERS: 1 | US FAERS | |
| 657 | Sleep Talking | FAERS: 1 | US FAERS | |
| 658 | Slow speech | FAERS: 1 | US FAERS | |
| 659 | Sneezing | FAERS: 1 | US FAERS | |
| 660 | Soft Tissue Infection | FAERS: 1 | US FAERS | |
| 661 | Splenic Infarction | FAERS: 1 | US FAERS | |
| 662 | Splenomegaly | FAERS: 1 | US FAERS | |
| 663 | Spondylitis | FAERS: 1 | US FAERS | |
| 664 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 665 | Status Epilepticus | FAERS: 1 | US FAERS | |
| 666 | Stress | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 667 | Sudden Cardiac Death | FAERS: 1 | US FAERS | |
| 668 | Tablet physical issue | FAERS: 1 | US FAERS | |
| 669 | Tachyarrhythmia | FAERS: 1 | US FAERS | |
| 670 | Tenosynovitis | FAERS: 1 | US FAERS | |
| 671 | Tension | FAERS: 1 | US FAERS | |
| 672 | Therapeutic product effect decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 673 | Throat cancer | FAERS: 1 | US FAERS | |
| 674 | Thrombosis in device | FAERS: 1 | US FAERS | |
| 675 | Thyroid hormones decreased | FAERS: 1 | US FAERS | |
| 676 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 677 | Toxic Optic Neuropathy | FAERS: 1 | US FAERS | |
| 678 | Troponin T increased | FAERS: 1 | US FAERS | |
| 679 | Unable to afford prescribed medication | FAERS: 1 | US FAERS | |
| 680 | Upper-airway cough syndrome | FAERS: 1 | US FAERS | |
| 681 | Ureteric perforation | FAERS: 1 | US FAERS | |
| 682 | Ureteritis | FAERS: 1 | US FAERS | |
| 683 | Urethral Obstruction | FAERS: 1 | US FAERS | |
| 684 | Urethral cancer metastatic | FAERS: 1 | US FAERS | |
| 685 | VIIth nerve paralysis | FAERS: 1 | US FAERS | |
| 686 | Venous occlusion | FAERS: 1 | US FAERS | |
| 687 | Viral upper respiratory tract infection | FAERS: 1 | US FAERS | |
| 688 | Vital functions abnormal | FAERS: 1 | US FAERS | |
| 689 | Vocal Cord Paralysis | FAERS: 1 | US FAERS | |
| 690 | Waist circumference increased | FAERS: 1 | US FAERS | |
| 691 | Wheezing | FAERS: 1 | US FAERS | |
| 692 | Wrong drug administered | FAERS: 1 | US FAERS | |
| 693 | Wrong patient received product | FAERS: 1 | US FAERS | |
| 694 | Wrong schedule | FAERS: 1 | US FAERS | |
| 695 | X-ray abnormal | FAERS: 1 | US FAERS | |
| 696 | furuncle | FAERS: 1 | US FAERS | |
| 697 | muscle injury | FAERS: 1 | US FAERS | |
| 698 | prostatitis | FAERS: 1 | US FAERS | |
| 699 | Alanine aminotransferase decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 700 | Ankle Fracture | Canada Vigilance: 1 | Canada Vigilance | |
| 701 | Bipolar Disorder | Canada Vigilance: 1 | Canada Vigilance | |
| 702 | Blood chloride decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 703 | Blood chloride increased | Canada Vigilance: 1 | Canada Vigilance | |
| 704 | Blood creatine phosphokinase decreased | Canada Vigilance: 2 | Canada Vigilance | |
| 705 | Blood creatinine decreased | Canada Vigilance: 5 | Canada Vigilance | |
| 706 | Blood sodium increased | Canada Vigilance: 2 | Canada Vigilance | |
| 707 | Human epidermal growth factor receptor decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 708 | Monocyte count increased | Canada Vigilance: 3 | Canada Vigilance | |
| 709 | Personality Change | Canada Vigilance: 1 | Canada Vigilance | |
| 710 | Prostatic Neoplasms, Castration-Resistant | 18985049 | CTD | |
| 711 | Prostatic Neoplasms | 21092758 22666205 | CTD | |
| 712 | Protein total decreased | Canada Vigilance: 3 | Canada Vigilance | |
| 713 | Protein urine present | Canada Vigilance: 1 | Canada Vigilance | |
| 714 | Red cell distribution width decreased | Canada Vigilance: 2 | Canada Vigilance | |
| 715 | Urine ketone body present | Canada Vigilance: 1 | Canada Vigilance | |
| 716 | Vascular occlusion | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120330
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.